ON 01910.Na (rigosertib) inhibits PI3K/Akt pathway and activates oxidative stress signals in head and neck cancer cell lines

Anil Prasad(Beth Israel Deaconess Medical Center), Benjamin S. Hoffman(Onconova Therapeutics (United States))
Oncotarget
October 15, 2016
Cited by 48


Related Papers